Study Advances Knowledge Base About Children and Adolescents With Myeloproliferative Neoplasms
The researchers uncovered higher-than-anticipated rates of thrombosis, hemorrhage, and transformation in their real-world cohort of MPN patients.
Hematologic Cancers
Online Educational Program Improves Patient Understanding in Myelodysplastic Syndromes
Researchers sought to determine whether an online educational program regarding myelodysplastic syndromes would provide benefits to learners’ understanding of MDS.
Targeted Radiotherapy Remains Important in Pediatric Hodgkin Lymphoma With Slow Early Response to Chemotherapy
Researchers sought to assess the importance of radiotherapy in pediatric patients with early‐stage low-risk classical Hodgkin lymphoma.
Response-Adapted Nivolumab Salvage Therapy Safe and Effective in Classical Hodgkin Lymphoma
Researchers sought to determine whether response-adapted sequential salvage therapy would be effective in patients with relapsed/refractory classical Hodgkin lymphoma.
Outcomes for Bacterial Meningitis in Patients With Multiple Myeloma
Researchers sought to determine the outcomes for patients with multiple myeloma who develop bacterial meningitis.
Zanubrutinib Bests Bendamustine-Rituximab in Previously Untreated CLL/SLL
Zanubrutinib can improve progression-free survival, when compared with bendamustine-rituximab, in previously untreated CLL/SLL, a phase 3 trial suggests.
COVID-19 Booster May Spur Seroconversion in Blood Cancer Patients
Among nonresponders to initial COVID-19 vaccination, seroconversion occurred in 56 percent following booster dose.
Illegitimate Online Pharmacies May Put Cancer Patients at Risk
Illegitimate online pharmacies are selling imatinib without a prescription, making false claims about being registered with regulatory bodies, and failing to provide patients with drug-related warnings.
Mosunetuzumab Demonstrates Activity in Relapsed/Refractory Follicular Lymphoma
Mosunetuzumab produced an objective response rate of 80%.
Measuring Circulating Tumor Cells at Diagnosis Can Improve Risk Stratification in Multiple Myeloma
Circulating tumor cell levels were an independent predictor of progression-free survival and overall survival.
- Loading...
Loading...
Next post in Multiple Myeloma
Loading... 
Loading...